Učitavanje...

Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid

Immunotherapy of murine autoimmune and allergic diseases by administration of peptides corresponding to the dominant T cell epitope is a reality. However, problems remain in applying this therapy to reduce antibody responses in humans. To overcome these difficulties, a preclinical system was develop...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jackson, D J, Elson, C J, Kumpel, B M
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2004
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809104/
https://ncbi.nlm.nih.gov/pubmed/15270840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02521.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!